University of Queensland Senior Group Leader Professor Trent Munro says he is hopeful the UQ vaccine will stay on course to be done within the projected 12 to 18 month timeline.
The coronavirus vaccine being developed by the University of Queensland remains a promising candidate in the field of treatments being created in labs across the globe. Trials have revealed it works for animals and produces no severe side effects in human studies. Professor Munro told Sky News host Peta Credlin large groups of people had entered efficacy testing for the virus and he was hopeful the results from those tests would be available as soon as possible.
“Being realistic, that’s probably going to be next year, but we’re all working as fast as we can,” he said. “Oxford are clearly ahead in terms of where they are on their large scale clinical trials, they’re already into phase three. “We’re working now with CSL to see how quickly we can get into phase three, but we’ve just got to make sure we take all those necessary steps.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Promising UQ coronavirus vaccine performs well in early trials | Sky News AustraliaThe coronavirus vaccine being developed by the University of Queensland remains a promising candidate in the field of treatments being created in labs across the globe.\n\nTrials have revealed it works for animals and produces no severe side effects in human studies. \n\nResearchers in the Netherlands found the vaccine, nicknamed S-clamp protected hamsters exposed to the virus that causes COVID-19. \n\nThe early stage Brisbane-based human trials have caused no major complications in the 120 participants after a single dose.\n
Read more »
UQ vaccine is showing 'phenomenal success' | Sky News AustraliaSky News host Paul Murray says a vaccine from University of Queensland is looking promising as it has shown no issues, side effects or problems.\n\t\nIn his The Good, The Bad, The Ugly segment on COVID-19, Mr Murray said the 'Good' was an Australian vaccine that has had “phenomenon success”.\n\n“University of Queensland has apparently had phenomenal success with what they have been looking at, phenomenal success particularly with animals that this has been trialed on, and phenomenal success when it comes to humans,” he said. \n\n“Basically, no problems, no side effects, no issues.\n\n“Well done to all of those very clever people.”\n
Read more »
One flying fox's 12,000km nomadic journey stuns researchersResearchers are reviewing everything they know about the nomadic habits of flying foxes after making a stunning discovery about the huge distances distance the creatures can travel.
Read more »
UQ vaccine is showing 'phenomenal success' | Sky News AustraliaSky News host Paul Murray says a vaccine from University of Queensland is looking promising as it has shown no issues, side effects or problems.\n\t\nIn his The Good, The Bad, The Ugly segment on COVID-19, Mr Murray said the 'Good' was an Australian vaccine that has had “phenomenon success”.\n\n“University of Queensland has apparently had phenomenal success with what they have been looking at, phenomenal success particularly with animals that this has been trialed on, and phenomenal success when it comes to humans,” he said. \n\n“Basically, no problems, no side effects, no issues.\n\n“Well done to all of those very clever people.”\n
Read more »
Promising UQ coronavirus vaccine performs well in early trials | Sky News AustraliaThe coronavirus vaccine being developed by the University of Queensland remains a promising candidate in the field of treatments being created in labs across the globe.\n\nTrials have revealed it works for animals and produces no severe side effects in human studies. \n\nResearchers in the Netherlands found the vaccine, nicknamed S-clamp protected hamsters exposed to the virus that causes COVID-19. \n\nThe early stage Brisbane-based human trials have caused no major complications in the 120 participants after a single dose.\n
Read more »
COVID-19 vaccine ‘ethically compromised’ | Sky News AustraliaThe Ethic Centre's Dr Simon Longstaff AO says the Oxford COVID-19 vaccine, developed using cell lines from a previously electively aborted foetus, is deeply problematic for those who believe all human life is sacred.\n\nThe COVID-19 vaccine being developed by Oxford University is proving an ethical dilemma for some as it uses cell lines from an electively aborted foetus. \n\nAn elective abortion is one that is carried out for no medical reason. \n\nDr Longstaff said the Oxford Vaccine was developed using the human foetal cell line HEK-293 which comes from human embryonic kidney cells from an elective abortion in the 1970s. \n\n“For some people, notably those who believe that all human life is sacred, the notion that they might be deriving some sort of benefit from such a source is deeply problematic and some would say, even against their conscience,' he said.\n\nImage: Getty
Read more »